Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer

被引:4
作者
Guckenberger, M. [1 ]
Saur, G. [1 ]
Wehner, D. [1 ]
Sweeney, R. A. [1 ]
Thalheimer, A. [2 ]
Germer, C. -T. [2 ]
Flentje, M. [1 ]
机构
[1] Univ Klinikum Wurzburg, Klin & Poliklin Strahlentherapie, D-97080 Wurzburg, Germany
[2] Univ Klinikum Wurzburg, Chirurg Klin 1, D-97080 Wurzburg, Germany
关键词
Rectal neoplasms; Prognosis; Radiotherapy; 5-Fluorouracil; Oxaliplatin; POSTOPERATIVE CHEMORADIOTHERAPY; ELDERLY-PATIENTS; FOLLOW-UP; INVOLVEMENT; MULTICENTER; SURVIVAL; TRIAL;
D O I
10.1007/s00066-012-0131-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this work was to perform a single institution comparison between preoperative short-course radiotherapy (SC-RT) and long-course radiochemotherapy (LC-RCHT) for locally advanced rectal cancer. A total of 225 patients with clinical stage UICC II-III rectal cancer were treated with SC-RT (29 Gy in 10 twice daily fractions followed by immediate surgery; n = 108) or LC-RCHT (54 Gy in 28 fractions with simultaneous 5-fluorouracil (5-FU) +/- oxaliplatin chemotherapy followed by delayed surgery; n = 117). All patients in the LC-RCHT cohort and patients in the SC-RT with pathological UICC stage a parts per thousand yenaEuro parts per thousand II received adjuvant chemotherapy. Before 2004, the standard of care was SC-RT with LC-RCHT reserved for patients where downstaging was considered as required for sphincter preservation or curative resection. In the later period, SC-RT was practiced only for patients unfit for radiochemotherapy. Patients in the LC-RCHT cohort had a significantly higher proportion of cT4 tumors, clinical node positivity, and lower tumor location. The 5-year local control (LC) and overall survival (OS) were 91% and 66% without differences between the SC-RT and LC-RCHT groups. Acute toxicity was increased during LC-RCHT (grade a parts per thousand yenaEuro parts per thousand II 1% vs. 33%) and there were no differences in postoperative complications. Severe late toxicity grade a parts per thousand yenaEuro parts per thousand III was increased after SC-RT (12% vs. 3%). Of patients aged > 80 years, 7 of 7 patients and 4 of 9 patients received curative surgery after SC-RT and LC-RCHT, respectively. Despite the fact that patients with worse prognostic factors were treated with LC-RCHT, there were no significant differences in LC and OS between the SC-RT and LC-RCHT group. Age > 80 years was identified as a significant risk factor for LC-RCHT and these patients could be treated preferably with SC-RT.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 50 条
  • [41] Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer
    Lee, Shing Fung
    Yip, Pui Lam
    Wo, Barry
    Wong, Natalie Sean-Man
    Vellayappan, Balamurugan A.
    Mamon, Harvey J.
    Lee, Francis Ann Shing
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [42] Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer
    Doi, Hiroshi
    Yokoyama, Hiroyuki
    Beppu, Naohito
    Fujiwara, Masayuki
    Harui, Shogo
    Kakuno, Ayako
    Yanagi, Hidenori
    Hishikawa, Yoshio
    Yamanaka, Naoki
    Kamikonya, Norihiko
    CANCERS, 2021, 13 (16)
  • [43] Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study
    Olafsdottir, Halla Sif
    Klevebro, Fredrik
    Ndegwa, Nelson
    Alexandersson von Dobeln, Gabriella
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [44] Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Sapienza, Lucas G.
    Raychaudhuri, Sreejata
    Nahlawi, Suraya K.
    Ozeir, Serene
    Abu-Isa, Eyad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [45] Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer
    Hoendervangers, Sieske
    Couwenberg, Alice M.
    Intven, Martijn P. W.
    van Grevenstein, Wilhelmina M. U.
    Verkooijen, Helena M.
    EJSO, 2018, 44 (07): : 1013 - 1017
  • [46] Current approaches in intensification of long-course chemoradiotherapy in locally advanced rectal cancer: a review
    Haddad, Peiman
    Ghalehtaki, Reza
    Saeedian, Arefeh
    Farhan, Farshid
    Babaei, Mohammad
    Aghili, Mahdi
    RADIATION ONCOLOGY JOURNAL, 2021, 39 (02): : 83 - 90
  • [47] Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial
    Nilsson, Per J.
    van Etten, Boudewijn
    Hospers, Geke A. P.
    Pahlman, Lars
    van de Velde, Cornelis J. H.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart
    Beukema, Jannet C.
    Kapiteijn, Ellen
    Marijnen, Corrie A. M.
    Nagtegaal, Iris D.
    Wiggers, Theo
    Glimelius, Bengt
    BMC CANCER, 2013, 13
  • [48] Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases
    Rades, Dirk
    Bohlen, Guenther
    Dunst, Juergen
    Lohynska, Radka
    Veninga, Theo
    Stalpers, Lukas
    Schild, Steven E.
    Dahm-Daphi, Jochen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (01) : 30 - 35
  • [49] Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy
    Moyer, Amber M.
    Vogel, Jon D.
    Lai, Samuel H.
    Kim, Hyun
    Chin, Re-, I
    Moskalenko, Marina
    Olsen, Jeffrey R.
    Birnbaum, Elisa H.
    Silviera, Matthew L.
    Mutch, Matthew G.
    Chapman, Brandon C.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (05) : 980 - 989
  • [50] Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial
    Aghili, Mahdi
    Khalili, Nastaran
    Khalili, Neda
    Babaei, Mohammad
    Farhan, Farshid
    Haddad, Peiman
    Salarvand, Samaneh
    Keshvari, Amir
    Fazeli, Mohammad Sadegh
    Mohammadi, Negin
    Ghalehtaki, Reza
    RADIATION ONCOLOGY JOURNAL, 2020, 38 (02): : 119 - 128